New online toolkit aims to ease cancer anxiety for rural seniors
NCT ID NCT07290543
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a web-based toolkit called CONNECT designed to help rural older adults who have survived cancer manage emotional distress and anxiety. The toolkit offers interactive activities, educational materials, and personalized mental health resource recommendations. Researchers will measure changes in distress levels and healthcare use over 12 months in 578 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 578 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Aug 2032
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * AIM 1: Invited by a member of the study team * AIM 1: In the following or related field: * Healthcare professionals (physicians, nurses, pharmacists, etc.) * Patient advocates and representatives * Researchers in healthcare or technology fields * Healthcare administrators and managers * AIM 1: Must be over 18 years old * AIM 1: English-speaking * AIM 1: Willing and able to provide informed consent * AIM 2 (RURAL OLDER CANCER SURVIVORS): A rural resident based on the Health Resources \& Services Administration (HRSA) rural analyzer * AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report of diagnosis with any cancer * AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report posttreatment (i.e., completion of curative intent therapy including surgery, chemotherapy, molecularly targeted, and endocrine therapy) * AIM 2 (RURAL OLDER CANCER SURVIVORS): Have access to a computer, a smartphone, or a tablet computer * AIM 2 (RURAL OLDER CANCER SURVIVORS): Aged \> 65 years old * AIM 2 (RURAL OLDER CANCER SURVIVORS): Assessed as having Cancer and Treatment Distress scale (CTXD) scores \> 0.85 at screening * AIM 2 (RURAL OLDER CANCER SURVIVORS): Have a caregiver willing to participate * AIM 2 (RURAL OLDER CANCER SURVIVORS): Non-institutionalized * AIM 2 (RURAL OLDER CANCER SURVIVORS): English proficient * AIM 2 (RURAL OLDER CANCER SURVIVORS): Willing and able to provide informed consent * AIM 2 (CAREGIVER): An identified informal caregiver of an eligible ROCS (caregivers include, but are not limited to, a child, partner, or friend; caregivers can reside in a rural or urban area and may or may not live with the ROCS * AIM 2 (CAREGIVER): Have internet access * AIM 2 (CAREGIVER): ≥ 18 years old * AIM 2 (CAREGIVER): Non-institutionalized * AIM 2 (CAREGIVER): English proficient * AIM 2 (CAREGIVER): Willing and able to provide informed consent * AIM 3 (FINAL WORKSHOP): Includes providers, medical and practice managers, patient care coordinators, and medical health technologists Exclusion Criteria: * AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the body of literature that reports increased distress associated with cancer recurrence * AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients * AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hematopoietic and lymphatic system neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine stop GI cancers from returning?
- Can a phone app help childhood cancer survivors keep track of their health?
- Can the way we word cancer research invitations boost participation?
- A chill pill for Chemo's side effects? cooling therapy and a Blood-Flow drug take on nerve pain
- Wearable tech could spot Post-Surgery problems early
- Can an AI chatbot ease the aftermath of cancer?